QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, March 14, 2007, 27(11):2751-2759; doi:10.1523/JNEUROSCI.3316-06.2007

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in J. Neurosci. Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Sontag, E. Articles by Bottiglieri, T. Search for Related Content PubMed PubMed Citation Articles by Sontag, E. Articles by Bottiglieri, T.

 Previous Article  |  Next Article 

Neurobiology of Disease
Protein Phosphatase 2A Methyltransferase Links Homocysteine Metabolism with Tau and Amyloid Precursor Protein Regulation

Estelle Sontag,¹ Viyada Nunbhakdi-Craig,¹ Jean-Marie Sontag,¹ Ramon Diaz-Arrastia,² Egon Ogris,³ Sanjana Dayal,⁴ Steven R. Lentz,⁴ Erland Arning,⁵ and Teodoro Bottiglieri⁵

¹Departments of Pathology and ²Neurology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, ³Department of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, A-1030 Vienna, Austria, ⁴Department of Internal Medicine, University of Iowa and Veterans Affairs Medical Center, Iowa City, Iowa 52242, and ⁵Institute of Metabolic Disease, Baylor University Medical Center, Dallas, Texas 75226

Correspondence should be addressed to Dr. Estelle Sontag, Department of Pathology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9073. Email: estelle.sontag{at}utsouthwestern.edu

Alzheimer's disease (AD) neuropathology is characterized by the accumulation of phosphorylated tau and amyloid-ß peptides derived from the amyloid precursor protein (APP). Elevated blood levels of homocysteine are a significant risk factor for many age-related diseases, including AD. Impaired homocysteine metabolism favors the formation of S-adenosylhomocysteine, leading to inhibition of methyltransferase-dependent reactions. Here, we show that incubation of neuroblastoma cells with S-adenosylhomocysteine results in reduced methylation of protein phosphatase 2A (PP2A), a major brain Ser/Thr phosphatase, most likely by inhibiting PP2A methyltransferase (PPMT). PP2A methylation levels are also decreased after ectopic expression of PP2A methylesterase in Neuro-2a (N2a) cells. Reduced PP2A methylation promotes the downregulation of B-containing holoenzymes, thereby affecting PP2A substrate specificity. It is associated with the accumulation of both phosphorylated tau and APP isoforms and increased secretion of ß-secretase-cleaved APP fragments and amyloid-ß peptides. Conversely, incubation of N2a cells with S-adenosylmethionine and expression of PPMT enhance PP2A methylation. This leads to the accumulation of dephosphorylated tau and APP species and increased secretion of neuroprotective -secretase-cleaved APP fragments. Remarkably, hyperhomocysteinemia induced in wild-type and cystathionine-ß-synthase +/– mice by feeding a high-methionine, low-folate diet is associated with increased brain S-adenosylhomocysteine levels, PPMT downregulation, reduced PP2A methylation levels, and tau and APP phosphorylation. We reported previously that downregulation of neuronal PPMT and PP2A methylation occur in affected brain regions from AD patients. The link between homocysteine, PPMT, PP2A methylation, and key CNS proteins involved in AD pathogenesis provides new mechanistic insights into this disorder.

Key words: Alzheimer's disease; cystathionine-ß-synthase; folate; homocysteine; methylation; PP2A

---

Received Aug. 1, 2006; revised Dec. 29, 2006; accepted Jan. 30, 2007.

Correspondence should be addressed to Dr. Estelle Sontag, Department of Pathology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9073. Email: estelle.sontag{at}utsouthwestern.edu

Related articles in J. Neurosci.:

This Week in The Journal

J. Neurosci. 2007 27: i. [Full Text]  

This article has been cited by other articles:

				C.-E Zhang, W. Wei, Y.-H. Liu, J.-H. Peng, Q. Tian, G.-P. Liu, Y. Zhang, and J.-Z. Wang Hyperhomocysteinemia Increases {beta}-Amyloid by Enhancing Expression of {gamma}-Secretase and Phosphorylation of Amyloid Precursor Protein in Rat Brain Am. J. Pathol., April 1, 2009; 174(4): 1481 - 1491. [Abstract] [Full Text] [PDF]

				J.-M. Sontag, V. Nunbhakdi-Craig, L. Montgomery, E. Arning, T. Bottiglieri, and E. Sontag Folate Deficiency Induces In Vitro and Mouse Brain Region-Specific Downregulation of Leucine Carboxyl Methyltransferase-1 and Protein Phosphatase 2A B{alpha} Subunit Expression That Correlate with Enhanced Tau Phosphorylation J. Neurosci., November 5, 2008; 28(45): 11477 - 11487. [Abstract] [Full Text] [PDF]

				R. J. Clarke and D. A. Bennett B Vitamins for Prevention of Cognitive Decline: Insufficient Evidence to Justify Treatment JAMA, October 15, 2008; 300(15): 1819 - 1821. [Full Text] [PDF]

				H.-S. Huang and E. Y. C. Lee Protein Phosphatase-1 Inhibitor-3 Is an in Vivo Target of Caspase-3 and Participates in the Apoptotic Response J. Biol. Chem., June 27, 2008; 283(26): 18135 - 18146. [Abstract] [Full Text] [PDF]

				G. R Seabrook, W. J. Ray, M. Shearman, and M. Hutton BEYOND AMYLOID: The Next Generation of Alzheimer's Disease Therapeutics Mol. Interv., October 1, 2007; 7(5): 261 - 270. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help